These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
525 related articles for article (PubMed ID: 21907261)
1. Purinergic signalling: from normal behaviour to pathological brain function. Burnstock G; Krügel U; Abbracchio MP; Illes P Prog Neurobiol; 2011 Oct; 95(2):229-74. PubMed ID: 21907261 [TBL] [Abstract][Full Text] [Related]
2. Introduction to Purinergic Signalling in the Brain. Burnstock G Adv Exp Med Biol; 2020; 1202():1-12. PubMed ID: 32034706 [TBL] [Abstract][Full Text] [Related]
3. Introduction to purinergic signalling in the brain. Burnstock G Adv Exp Med Biol; 2013; 986():1-12. PubMed ID: 22879061 [TBL] [Abstract][Full Text] [Related]
4. Purinergic signalling: Its unpopular beginning, its acceptance and its exciting future. Burnstock G Bioessays; 2012 Mar; 34(3):218-25. PubMed ID: 22237698 [TBL] [Abstract][Full Text] [Related]
5. Purinergic Signalling and Neurological Diseases: An Update. Burnstock G CNS Neurol Disord Drug Targets; 2017; 16(3):257-265. PubMed ID: 27658510 [TBL] [Abstract][Full Text] [Related]
6. Introduction to Purinergic Signaling. Burnstock G Methods Mol Biol; 2020; 2041():1-15. PubMed ID: 31646477 [TBL] [Abstract][Full Text] [Related]
7. Membrane compartments and purinergic signalling: P2X receptors in neurodegenerative and neuroinflammatory events. Apolloni S; Montilli C; Finocchi P; Amadio S FEBS J; 2009 Jan; 276(2):354-64. PubMed ID: 19076216 [TBL] [Abstract][Full Text] [Related]
8. Involvement of P2 receptors in the growth and survival of neurons in the CNS. Franke H; Illes P Pharmacol Ther; 2006 Mar; 109(3):297-324. PubMed ID: 16102837 [TBL] [Abstract][Full Text] [Related]
9. Purinergic signalling: past, present and future. Burnstock G Braz J Med Biol Res; 2009 Jan; 42(1):3-8. PubMed ID: 18853040 [TBL] [Abstract][Full Text] [Related]
10. An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration. Burnstock G Neuropharmacology; 2016 May; 104():4-17. PubMed ID: 26056033 [TBL] [Abstract][Full Text] [Related]
11. Purinergic signalling at the plasma membrane: a multipurpose and multidirectional mode to deal with amyotrophic lateral sclerosis and multiple sclerosis. Amadio S; Apolloni S; D'Ambrosi N; Volonté C J Neurochem; 2011 Mar; 116(5):796-805. PubMed ID: 21214557 [TBL] [Abstract][Full Text] [Related]
12. Historical review: ATP as a neurotransmitter. Burnstock G Trends Pharmacol Sci; 2006 Mar; 27(3):166-76. PubMed ID: 16487603 [TBL] [Abstract][Full Text] [Related]
14. Purinergic signalling and disorders of the central nervous system. Burnstock G Nat Rev Drug Discov; 2008 Jul; 7(7):575-90. PubMed ID: 18591979 [TBL] [Abstract][Full Text] [Related]
16. Purinergic receptors in psychiatric disorders. Krügel U Neuropharmacology; 2016 May; 104():212-25. PubMed ID: 26518371 [TBL] [Abstract][Full Text] [Related]
17. Adenosine and ATP receptors in the brain. Burnstock G; Fredholm BB; Verkhratsky A Curr Top Med Chem; 2011; 11(8):973-1011. PubMed ID: 21401499 [TBL] [Abstract][Full Text] [Related]